Yahoo Finance Tesla Stock Triggers Sell Signal As Booming BYD Eyes BEV Crown
Tesla stock triggered a sell signal. BYD is in a buy zone after revenue topped Tesla for the first time. The China EV giant eying the BEV crown too.
Tesla stock triggered a sell signal. BYD is in a buy zone after revenue topped Tesla for the first time. The China EV giant eying the BEV crown too.
Want to give your eyes a youthful sparkle? Try this top-seller from Tarte in an unexpected color.
It has also raised prices of its plans in the U.S. to capitalize on demand for its premium products. Spotify expects operating income of 481 million euros ($509.76 million) in the fourth quarter, compared with the LSEG-compiled average analysts' estimate of 445.7 million euros. Its forecast for monthly active users (MAUs) of 665 million was also above estimates of 661 million, according to Visible Alpha.
Investors are assessing whether the post-election rally is about to stall and what Donald Trump's Cabinet picks mean for policy.
LOUISVILLE, Ky. (AP) — A pregnant woman filed a lawsuit Tuesday seeking the right to an abortion in Kentucky in the latest challenge to the state's near-total ban on the procedure.
Home Depot narrowed 2024 guidance early Tuesday after beating earnings and sales estimates for the third quarter. Home Depot stock fell in a buy area. The home improvement store giant is now guiding a 1% decline in adjusted earnings per share for the full year vs. its prior forecast for a 1%-3% drop.
An explosion has been reported at a business in Louisville, Kentucky, officials confirmed.
Warren Buffett-backed Occidental Petroleum reports third-quarter earnings late Tuesday, with analysts expecting a 37% drop in profits as investors focus on how the Permian Basin oil producer plans to reduce debt and clean up its balance sheet. Ahead of Occidental's Tuesday report, analysts predict Q3 EPS coming in at 74 cents per share, down 37% compared to $1.18 per share a year ago, with revenue totaling $7.12 billion, running basically flat vs. Q3 2023. Occidental Petroleum is coming off a big expectations beat in Q2, when it saw a surprise 51% profit increase, breaking a string of five consecutive quarterly earnings declines.
You could say that Ethan Slater's yellow brick road to getting cast in the big screen adaptation of “Wicked” had an element of magic to it. On the day he was asked to submit a tape of himself for the role of Boq, Slater was playing the part of actor Christopher Fitzgerald's identical twin in a table read for a potential musical. Fitzgerald originated the role of Boq in “Wicked” on Broadway.
Outlook key for Mediterranean-themed restaurant chain Cava after Chipotle invested in rival Brassica.
TORONTO, November 12, 2024--Westaim had a net loss of $1.1 million ($0.01 diluted loss per share) for Q3 2024; YTD net profit of $5.1 million ($0.04 diluted EPS)
Advanced myostatin program with dosing underway in non-human primate studySAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) today reported financial results for the fiscal first quarter ended September 30, 2024 and provided a corporate update on its progress. “In our fiscal first quarter we advanced our collaboration with AstralBio, manufacturing and dosing a lead molecule with therapeutic potential for muscle wasting and obesity in non-human primate in vivo studies and progre
SAN DIEGO, November 12, 2024--SOLVD Health, a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has received U.S. Food and Drug Administration (FDA) PMA supplement approval for its INFINITI High Throughput System (HTS) to be used with AvertD®.
Appointed Douglas Williams, Ph.D. as Chair of the Board of Directors FDA Clearance of Investigational New Drug Application (IND) for systemic lupus erythematosus (SLE) Expanded Management Team with the Appointment of Gary Hao, Ph.D. as Vice President of Chemistry, Manufacturing and Controls Highlights Timing of Key Upcoming Milestones Cash Runway Remains through 2027 Expected to Enable Delivery of Key Value Inflection Points WELLESLEY HILLS, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Climb Bio, In
Interim data from initial dose escalation cohorts of Phase 1 CARDINAL trial evaluating TERN-701 (allosteric BCR-ABL tyrosine kinase inhibitor) in chronic myeloid leukemia (CML) expected in early December 2024 Plans to initiate Phase 2 clinical trial for TERN-601 in obesity in early 2Q25 with initial 12-week data expected in 2H25 Cash, cash equivalents and marketable securities of $372.8 million, including $172.7 million equity raise in September, expected to provide runway into 2028 FOSTER CITY,
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue increase for Q3 2024, driven primarily by Dapibus™ license fees and milestone payments.Received $1 million milestone payment for animal-free recombinant albumin products.Received $425,000 success fees for achieving production targets in a dairy enzyme collaboration.Expanded recombinant life science protein portfo
DENVER, Nov. 12, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, announced today the hiring of Josh McCarter as the leader of its EverPro home and field services vertical, reporting to Company founder and CEO Eric Remer. Mr. McCarter brings 25 years of technology experience to EverCommerce, spanning ecommerce, vertical SaaS, consumer marketplaces and integrated Fintech. He joined EverCommerce from ShipMonk where he served as CEO e
BOCA RATON, Fla., November 12, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the third quarter ended September 30, 2024.
Delivered Total and Net Investment Income of $36.7 million and $15.9 million, RespectivelyInvestment Portfolio of $1.1 billionConference Call Today, Tuesday, November 12, 2024, at 5:00 p.m. ET MENLO PARK, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced its financial results for the t
Presented preclinical data further supporting the potential best-in-class profile of ORIC-114 to treat EGFR exon 20 insertions and other atypical mutations at the EORTC-NCI-AACR Conference Announced clinical collaborations with multiple strategic partners to support ongoing trial evaluating ORIC-944 in combination with AR inhibitors for the treatment of prostate cancer Cash and investments of $282.4 million expected to fund operating plan into late 2026 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO,
WEST FARGO, N.D., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the third quarter ended October 31, 2024, on Tuesday, November 26, 2024, followed by an investor conference call at 7:30 a.m. Central time (8:30 a.m. Eastern time). Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. International cal